Brief: Formycon Says Co Secures License Date For Fyb203 Biosimilar In Europe & Further Territories
19/03/2026 05:32
March 19 (Reuters) - Formycon AG FYB.DE: FORMYCON AG - SECURES LICENSE DATE FOR FYB203 BIOSIMILAR IN EUROPE AND FURTHER TERRITORIES FORMYCON AG - MARKET LAUNCHES FOR FYB203 IN EUROPE TO START IN MAY 2026 Source text: ID:nEQ4sJvdZa Further company coverage: FYB.DE ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Formycon AG
See all newsGermany's Formycon Q1 revenue more than doubles, EBITDA loss narrows
Brief: Formycon Q1 Revenue EUR 13.1 Million
Brief: Eqs-News Formycon Aflibercept Biosimilars Ahzantive® And Baiama® Are Now Available In The European Union
Brief: Formycon AG Reports FY25 Group Revenue EUR 44.5 Million
Brief: Formycon Says Co Secures License Date For Fyb203 Biosimilar In Europe & Further Territories